Chemical and advanced materials maker, Celanese Corporation CE presented a webinar on “New Tribologically Modified POM MT Grades for Complex Medical Devices” on Apr 9. This webinar was hosted by industry-leading medical materials association, Qmed.
The new POM MT is a thermoplastic polymer which helps in the production of medical devices with very low friction and wear, and minimal squeaking noise during operation. These products also eradicate the need for external lubrication as the new materials operate smoothly, providing patients with a high degree of comfort as well as consistency from the very first use.
Wendy Johnson and Kirsten Markgraf, medical marketing manager and product development leader at Celanese, respectively, highlighted the company’s new cutting-edge technology, related properties, easy processability, and enhanced patient comfort.
Celanese has emerged as a global leader in terms of supplying its world-class products to the medical industry. The company continues to improve its engineered polymers portfolio to meet the rising demand and end-use applications of its medical suppliers.
Celanese’s strong presence in the emerging markets will enable it to deliver incremental earnings in 2015. Earnings are expected to be driven by company-specific initiatives, including product innovation and enhancement of efficiencies through productivity. The company expects its business strength to offset the volatility in the macro environment this year.
Celanese currently carries a Zacks Rank #3 (Hold).
Better-ranked stocks in the diversified chemical space include Innospec Inc. IOSP, Stepan Company SCL and Akzo Nobel NV AKZOY. While Innospec and Stepan Company sport a Zacks Rank #1 (Strong Buy), Akzo Nobel carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment